PE-backed Junshi Biosciences shines on Star Market debut
PE-backed Junshi Biosciences has become the first Chinese biotech company to list in Hong Kong and the mainland, following a strong debut on Shanghai's Star Market.
Junshi, which counts Loyal Valley Capital and Hillhouse Capital among its investors, raised RMB4.83 billion ($691 million) in its IPO, selling 87 million shares at RMB55.5 apiece. The stock opened...
More on Healthcare
Latest News
PE-backed JD Health files for Hong Kong IPO
JD Health, the healthcare unit of Chinese e-commerce giant JD.com, has filed for Hong Kong IPO. The company’s backers include Hillhouse Capital, CPE, CICC Capital, and Baring Private Equity Asia.
General Atlantic invests $500m in India's Reliance Retail
General Atlantic has become the third global GP to double down on Reliance Industries’ plans to reinvent digital consumer services in India, following its earlier commitment to Jio Platforms with an investment in the conglomerate’s retail unit.
Deal focus: Green Monday finds mission-aligned investors
Green Monday, the Hong Kong plant-based food distributor behind the Green Common retail chain and OmniPork alternative meats, has raised its first institutional round of funding.
AVCJ daily bulletin returns October 5
AVCJ's daily bulletin will not be published on October 1 or 2 due to consecutive public holidays in Hong Kong.